Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2010-12-21
pubmed:abstractText
Dyslipidaemia is an important but modifiable risk factor of cardiovascular disease (CVD) in type 2 diabetes. Yet, the effectiveness of lipid regulating drugs in Asians is lacking. We examined the effects of lipid control and treatment with lipid regulating drugs on new onset of CVD in Chinese type 2 diabetic patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1475-2840
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
77
pubmed:meshHeading
pubmed-meshheading:21092182-Adult, pubmed-meshheading:21092182-Aged, pubmed-meshheading:21092182-Aged, 80 and over, pubmed-meshheading:21092182-Asian Continental Ancestry Group, pubmed-meshheading:21092182-Biological Markers, pubmed-meshheading:21092182-Cardiovascular Diseases, pubmed-meshheading:21092182-China, pubmed-meshheading:21092182-Cholesterol, HDL, pubmed-meshheading:21092182-Cholesterol, LDL, pubmed-meshheading:21092182-Diabetes Mellitus, Type 2, pubmed-meshheading:21092182-Dyslipidemias, pubmed-meshheading:21092182-Female, pubmed-meshheading:21092182-Humans, pubmed-meshheading:21092182-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:21092182-Lipids, pubmed-meshheading:21092182-Male, pubmed-meshheading:21092182-Middle Aged, pubmed-meshheading:21092182-Proportional Hazards Models, pubmed-meshheading:21092182-Prospective Studies, pubmed-meshheading:21092182-Registries, pubmed-meshheading:21092182-Risk Assessment, pubmed-meshheading:21092182-Risk Factors, pubmed-meshheading:21092182-Time Factors, pubmed-meshheading:21092182-Treatment Outcome, pubmed-meshheading:21092182-Triglycerides
pubmed:year
2010
pubmed:articleTitle
Lipid control and use of lipid-regulating drugs for prevention of cardiovascular events in Chinese type 2 diabetic patients: a prospective cohort study.
pubmed:affiliation
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't